Shah P - Search Results

1

Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes.

Vella A, Shah P, Basu R, Basu A, Holst JJ, Rizza RA. Vella A, et al. Among authors: shah p. Diabetes. 2000 Apr;49(4):611-7. doi: 10.2337/diabetes.49.4.611. Diabetes. 2000. PMID: 10871199 Clinical Trial.

2

Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.

Basu R, Basu A, Nielsen M, Shah P, Rizza RA. Basu R, et al. Among authors: shah p. J Clin Endocrinol Metab. 1999 Jul;84(7):2314-9. doi: 10.1210/jcem.84.7.5860. J Clin Endocrinol Metab. 1999. PMID: 10404795

3

Impact of lack of suppression of glucagon on glucose tolerance in humans.

Shah P, Basu A, Basu R, Rizza R. Shah P, et al. Am J Physiol. 1999 Aug;277(2):E283-90. doi: 10.1152/ajpendo.1999.277.2.E283. Am J Physiol. 1999. PMID: 10444424

4

Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity.

Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA. Basu A, et al. Among authors: shah p. Diabetes. 2000 Feb;49(2):272-83. doi: 10.2337/diabetes.49.2.272. Diabetes. 2000. PMID: 10868944

5

Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA. Shah P, et al. J Clin Endocrinol Metab. 2000 Nov;85(11):4053-9. doi: 10.1210/jcem.85.11.6993. J Clin Endocrinol Metab. 2000. PMID: 11095432

6

Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.

Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA. Vella A, et al. Among authors: shah p. Diabetes. 2001 Mar;50(3):565-72. doi: 10.2337/diabetes.50.3.565. Diabetes. 2001. PMID: 11246876

7

Systemic and regional free fatty acid metabolism in type 2 diabetes.

Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD. Basu A, et al. Among authors: shah p. Am J Physiol Endocrinol Metab. 2001 Jun;280(6):E1000-6. doi: 10.1152/ajpendo.2001.280.6.E1000. Am J Physiol Endocrinol Metab. 2001. PMID: 11350782 Free article. Clinical Trial.

8

Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity.

Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA. Basu A, et al. Among authors: shah p. Diabetes. 2001 Jun;50(6):1351-62. doi: 10.2337/diabetes.50.6.1351. Diabetes. 2001. PMID: 11375336

9

Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration.

Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Vella A, et al. Among authors: shah p. Diabetologia. 2001 Jun;44(6):729-37. doi: 10.1007/s001250051682. Diabetologia. 2001. PMID: 11440366

10

Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans.

Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA. Shah P, et al. Diabetes. 2002 Feb;51(2):301-10. doi: 10.2337/diabetes.51.2.301. Diabetes. 2002. PMID: 11812736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,372 results

Search Page

Filters